Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label StudyFrancesco Di Pierro, Sagheer Ahmed, Pietro Allegrini et al.|International Journal of General Medicine|2021Cited by 183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical TrialFrancesco Di Pierro, Saeed Khan, Somia Iqtadar et al.|International Journal of General Medicine|2021Cited by 177
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trialFrancesco Di Pierro, Nicola Zerbinati, Amjad Khan et al.|Frontiers in Pharmacology|2023Cited by 54